These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Early eradication of factor VIII inhibitor in patients with congenital hemophilia A by immune tolerance induction with a high dose of immunoglobulin. Mizoguchi Y, Furue A, Kagawa R, Chijimatsu I, Tomioka K, Shimomura M, Imanaka Y, Nishimura S, Saito S, Miki M, Ono A, Konishi N, Kawaguchi H, Kobayashi M. Int J Hematol; 2016 Apr; 103(4):473-7. PubMed ID: 26830966 [Abstract] [Full Text] [Related]
5. The immune tolerance induction (ITI) dose debate: does the International ITI Study provide a clearer picture? Ettingshausen CE, Kreuz W. Haemophilia; 2013 Jan; 19 Suppl 1():12-7. PubMed ID: 23278995 [Abstract] [Full Text] [Related]
8. Successful immune tolerance induction with low-dose coagulation factor VIII in a patient with hemophilia A from a developing country. Ay Y, Ersin T, Yesim O, Hilkay KT, Dilek I, Gulcihan O, Ahmet K. Blood Coagul Fibrinolysis; 2016 Sep; 27(6):729-31. PubMed ID: 26484639 [Abstract] [Full Text] [Related]